Consulting
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Unlock global pharma market insights with expert consulting analysis. Drive strategic decisions for investors, BD, and regulatory teams.
Showing 1–10 of 10 articles
Quick answer
NovaPharmaNews Consulting hub for FDA covers 10 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Obesity rates in America by year: what the data shows
Listeria Outbreak in Soft Cheese: FDA Investigation and Industry Impact
Revolution Medicines' Daraxonrasib: Pancreatic Cancer Breakthrough and Beyond
CDC: Ebola outbreak in Central Africa could reach 20,000 cases without strong countermeasures
Rx Rundown: Pfizer, Hikma Pharmaceuticals, NewLimit — Drug Approvals & Catalyst Tracker
MIRA Pharma Consolidates Global Rights to MIRA-55 and SKNY-1
4 Biotech Stocks Investors Should Watch in 2026: Market Analysis
Texas AG Investigating Energy Drinks: What Pharma Teams Need to Know
Top 10 Biopharma M&A Deals of 2025: Market Analysis
Pharma M&A Round-Up: April 2026 Insights and Analysis
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.